Immunostaining intensity was assessed quantitatively by immunohistomorphometry using ImageJ software (National Institutes of Health, Bethesda, MD), as described previously[48]
According to the FDA, a drug may be compounded for a patient who cannot receive treatment with an FDA-approved drug
Health Canada has stated in public advisories that unauthorized injectable peptide products are illegal regardless of 'research use only' labelling, which means administration to a person or animal would step outside the lawful use scope of this product
15 Overall, it favors that ALC could serve as a potential treatment and plays role as a potential biomarker for MDD
Early warning signs include persistent fatigue that does not improve with rest, difficulty concentrating or brain fog, tingling or numbness in hands and feet, weakness in the legs, dizziness when standing up, pale or yellowish skin, and a sore or swollen tongue